BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3917576)

  • 1. Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.
    Schultz AM; Henderson LE; Oroszlan S; Garber EA; Hanafusa H
    Science; 1985 Jan; 227(4685):427-9. PubMed ID: 3917576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.
    Pellman D; Garber EA; Cross FR; Hanafusa H
    Nature; 1985 Mar 28-Apr 3; 314(6009):374-7. PubMed ID: 3920530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.
    Buss JE; Sefton BM
    J Virol; 1985 Jan; 53(1):7-12. PubMed ID: 2981363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of p60v-src to its myristylated membrane-bound form.
    Garber EA; Cross FR; Hanafusa H
    Mol Cell Biol; 1985 Oct; 5(10):2781-8. PubMed ID: 3016513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant.
    Kaplan JM; Mardon G; Bishop JM; Varmus HE
    Mol Cell Biol; 1988 Jun; 8(6):2435-41. PubMed ID: 2841581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine structural mapping of a critical NH2-terminal region of p60src.
    Pellman D; Garber EA; Cross FR; Hanafusa H
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1623-7. PubMed ID: 2984663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.
    Kamps MP; Buss JE; Sefton BM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4625-8. PubMed ID: 2991884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.
    Buss JE; Kamps MP; Gould K; Sefton BM
    J Virol; 1986 May; 58(2):468-74. PubMed ID: 3009860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.
    Henderson LE; Krutzsch HC; Oroszlan S
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):339-43. PubMed ID: 6340098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein.
    Buss JE; Kamps MP; Sefton BM
    Mol Cell Biol; 1984 Dec; 4(12):2697-704. PubMed ID: 6441887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The six amino-terminal amino acids of p60src are sufficient to cause myristylation of p21v-ras.
    Buss JE; Der CJ; Solski PA
    Mol Cell Biol; 1988 Sep; 8(9):3960-3. PubMed ID: 3146693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.
    Cross FR; Garber EA; Pellman D; Hanafusa H
    Mol Cell Biol; 1984 Sep; 4(9):1834-42. PubMed ID: 6092942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus.
    Sefton BM; Walter G
    J Virol; 1982 Nov; 44(2):467-74. PubMed ID: 6292511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide.
    Nigg EA; Sefton BM; Hunter T; Walter G; Singer SJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5322-6. PubMed ID: 6291037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-fatty acyl compounds inhibit myristoyl acylation of pp60v-src and reduce tumorigenicity of Rous sarcoma virus-infected cells.
    Shoji S; Tsujita R; Hamuro T; Funakoshi T; Kubota Y
    Biochem Int; 1991 Jan; 23(1):15-23. PubMed ID: 1650555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus.
    Sefton BM; Hunter T; Ball EH; Singer SJ
    Cell; 1981 Apr; 24(1):165-74. PubMed ID: 6263485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation and metabolism of the transforming protein of Rous sarcoma virus.
    Sefton BM; Patschinsky T; Berdot C; Hunter T; Elliott T
    J Virol; 1982 Mar; 41(3):813-20. PubMed ID: 6178840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src.
    Iba H; Cross FR; Garber EA; Hanafusa H
    Mol Cell Biol; 1985 May; 5(5):1058-66. PubMed ID: 2582236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation by p60src with altered N-terminal sequences.
    Hanafusa H; Garber EA; Hanafusa T
    Princess Takamatsu Symp; 1986; 17():233-40. PubMed ID: 2843496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.
    Schultz AM; Oroszlan S
    J Virol; 1983 May; 46(2):355-61. PubMed ID: 6302307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.